Structure−Activity Relationships and Binding Mode of Styrylquinolines as Potent Inhibitors of HIV-1 Integrase and Replication of HIV-1 in Cell Culture
- 22 March 2000
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 43 (8), 1533-1540
- https://doi.org/10.1021/jm990467o
Abstract
Our prior studies showed that polyhydroxylated styrylquinolines are potent HIV-1 integrase (IN) inhibitors that block the replication of HIV-1 in cell culture at nontoxic concentrations. To explore the mechanism of action of these inhibitors, various novel styrylquinoline derivatives were synthesized and tested against HIV-1 IN and in cell-based assays. Regarding the in vitro experiments, the structural requirements for biological activity are a carboxyl group at C-7, a hydroxyl group at C-8 in the quinoline subunit, and an ancillary phenyl ring. However the in vitro inhibitory profile tolerates deep alterations of this ring, e.g. by the introduction of various substituents or its replacement by heteroatomic nuclei. Regarding the ex vivo assays, the structural requirements for activity are more stringent than for in vitro inhibition. Thus, in addition to an o-hydroxy acid group in the quinoline, the presence of one ortho pair of substituents at C-3‘ and C-4‘, particularly two hydroxyl groups, in the ancillary phenyl ring is imperatively required for inhibitory potency. Starting from literature data and the SARs developed in this work, a putative binding mode of styrylquinoline inhibitors to HIV-1 IN was derived.Keywords
This publication has 16 references indexed in Scilit:
- Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral TherapyNew England Journal of Medicine, 1999
- Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral TherapyNew England Journal of Medicine, 1999
- Diversity Analysis of 14 156 Molecules Tested by the National Cancer Institute for Anti-HIV Activity Using the Quantitative Structure−Activity Relational Expert System MCASEJournal of Medicinal Chemistry, 1999
- Structure-Activity of Tetrad-forming Oligonucleotides as a Potent Anti-HIV Therapeutic DrugPublished by Elsevier BV ,1998
- Geometrically and Conformationally Restrained Cinnamoyl Compounds as Inhibitors of HIV-1 Integrase: Synthesis, Biological Evaluation, and Molecular ModelingJournal of Medicinal Chemistry, 1998
- Styrylquinoline Derivatives: A New Class of Potent HIV-1 Integrase Inhibitors That Block HIV-1 Replication in CEM CellsJournal of Medicinal Chemistry, 1998
- Cobalamin Inhibition of HIV-1 Integrase and Integration of HIV-1 DNA into Cellular DNABiochemical and Biophysical Research Communications, 1998
- Viral Dynamics in HIV-1 InfectionCell, 1998
- Design and discovery of HIV-1 integrase inhibitorsDrug Discovery Today, 1997
- HIV-1 DNA integration: Mechanism of viral DNA cleavage and DNA strand transferCell, 1991